Long R3 IGF-1 — Long-acting IGF-1 analogue with ~20-30 hour half-life — the most-studied form of IGF-1 in research applications.
GLP-1 Analogue — Long-acting GLP-1 receptor agonist studied for metabolic regulation, glucose homeostasis, and body composition research.
Thymosin Beta-4 Fragment — Synthetic Thymosin Beta-4 fragment studied for actin regulation, cellular migration, angiogenesis, and recovery research.